F-Star Appoints CSO
This article was originally published in Scrip
F-Star, a company focused on immuno-oncology, has appointed Neil Brewis chief scientific officer. Brewis joins the company from GlaxoSmithKline where he was vice-president, head of biopharmaceutical research. Prior to this, he was head of research for Domantis, until it was acquired by GSK in 2007.